Abstract
Purpose
The purpose of this study was to analyze indocyanine green (ICG) angiographic findings of Dalen-Fuchs nodules in Vogt-Koyanagi-Harada (VKH) disease.
Methods
ICG angiograms of 15 patients (30 eyes) with Dalen-Fuchs nodules in VKH disease of between 2 months and 5 years after the initial diagnosis were retrospectively studied. Findings of ICG angiography were compared with features of fundus fluorescein angiography (FFA).
Results
Dalen-Fuchs nodules were easily found in the inferior (30 eyes, 100%) and temporal periphery (22 eyes, 73%) and showed two kinds of fluorescence in ICG angiography. In ten patients (20 eyes), the nodules showed small round hypofluorescent dark dots in the whole process of angiography, and the dark dots were larger in size than the nodules in FFA. Disease course in these patients was relatively long—between 1 year and 5 years. On clinical examination, the nodules were atrophic, and hyperpigmentation was found around them. In another five patients (ten eyes), parts of the nodules showed small hyperfluorescent dots in the early phase, but they were faint in the intermediate phase and became large, hypofluorescent dark dots in the late phase. Disease course in these patients was between 2 and 8 months. The nodules were bright yellow, fresh, and much larger than those in the first kind of ICG fluorescence.
Conclusions
Dalen-Fuchs nodules in VKH are mostly present in the inferior and temporal periphery. The two kinds of fluorescence of Dalen-Fuchs in ICG angiography may reflect obliteration of choriocapillaris under the nodules and different quantities of lipofuscin in the nodules at different time points of the disease.
Similar content being viewed by others
References
Allinson RW, Le TD, Kramer TR, Snyder RW (1993) Fluorescein angiographic appearance of Dalen-Fuchs nodules in sympathetic ophthalmia. Ann Ophthalmol 25:152–154
Dalén A (1904) Zur Kenntnis der sogenannten Chorioiditis sympathica. Mitt Augenklinik des Carolin Med Chirurg Instit z Stockholm 6:1–21
Evans M, Rao NA (2005) Vogt-Koyanagi-Harada disease. Int Opthalmol Clin 45:115–134
Font RL, Fine BS, Messmer E, Rowsey JF (1983) Light and electron microscopic study of Dalen-Fuchs nodules in sympathetic ophthalmia. Ophthalmology 89:66–75
Fuchs E (1905) uber sympathisierende Entzundung (nebst Bemerkungen) über seröse traumatische iritis). Albrecht von Graefe’s Arch Klin Ophthalmol 61:365–456
Herbort CP, LeHoang P, Crosier YG (1998) Schematic interpretation of indocyanine green angiography in posterior uveitis using a standard angiographic protocol. Ophthalmology 105:432–440
Inomata H, Rao NA (2001) Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. Am J Ophthalmol 131:607–614
Ishikawa T, Ikui H (1972) The fine structure of the Dalen-Fuchs nodule in sympathetic ophthalmia. Ophthalmology 90:66–75
Jennings T, Tessler HH (1989) Twenty cases of sympathetic ophthalmia. Br J Ophthalmol 73:140–145
Piccolino FC, Borgia L, Zinicola E, Lester M, Torrielli S (1996) Pre-injection fluorescence in indocyanine green angiography. Ophthalmology 103:1837–1845
Read RW, Holland GN, Rao NA et al (2001) Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131:647–652
Reynard M, Riffenburgh R, Minckler DS (1985) Morphological variation of Dalen-Fuchs nodules in sympathetic ophthalmia. Br J Ophthalmol 69:197–201
Sharp DC, Bell RA, Patterson E, Pinkerton RMH (1984) Sympathetic ophthalmia: Histopathologic and fluorescein angiographic correlation. Arch Ophthalmol 102:232–235
Acknowledgement
This study was supported in part by the National Natural Science Foundation of China (grant no. 30271669) and the Natural Science Foundation of Guangdong Province (grant no. 04009333).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, W., Wen, F., Huang, S. et al. Indocyanine green angiographic findings of Dalen-Fuchs nodules in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol 245, 937–940 (2006). https://doi.org/10.1007/s00417-006-0511-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-006-0511-3